{"id":9141,"date":"2018-09-11T08:10:00","date_gmt":"2018-09-11T06:10:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/"},"modified":"2018-09-11T08:10:00","modified_gmt":"2018-09-11T06:10:00","slug":"irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/","title":{"rendered":"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

IRLAB har erh\u00e5llit notice of allowance fr\u00e5n United States Patent and Trademark Office (USPTO) avseende ett patent riktat mot n\u00e4sta generation substanser f\u00f6r behandling av hj\u00e4rnans sjukdomar. Detta betyder att ett patent, baserat p\u00e5 uppt\u00e4ckter gjorda med IRLAB forskningsplattform, ISP, och som avser nyckelsubstanser inom forskningsprogrammet P001, kommer att godk\u00e4nnas.<\/strong><\/div>\n
\u201dDetta \u00e4r ett viktigt steg i v\u00e5rt forskningsprogram P001 och v\u00e5r str\u00e4van mot n\u00e4sta generation substanser f\u00f6r effektiv behandling av sjukdomar i r\u00f6relseapparaten samt psykisk och kognitiv oh\u00e4lsa. Patentet kommer st\u00e4rka v\u00e5r patentportf\u00f6lj ytterligare och m\u00f6jligg\u00f6r valet av nya l\u00e4kemedelskandidater i v\u00e5rt arbete att uppt\u00e4cka och utveckla nya f\u00f6rb\u00e4ttrade behandlingar av hj\u00e4rnans sjukdomar\u201d, s\u00e4ger Dr Clas Sonesson, IRLAB:s Chief Scientific Officer.<\/p><\/pre>\n
\n
F\u00f6r vidare information<\/strong><\/p>\n
Nicholas Waters, VD\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0
Tel: +46 730 75 77 01\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0 \u00a0\u00a0
E-post: nicholas.waters@irlab.se<\/a><\/p>\n
Clas Sonesson, CSO\u00a0
Tel: +46 730 75 77 00
E-post: clas.sonesson@irlab.se<\/p>\n<\/div>\n
\n
Om IRLAB<\/strong><\/p>\n
IRLAB \u00e4r ett forsknings- och utvecklingsbolag, listat p\u00e5 Nasdaq First North Premier som fokuserar p\u00e5 utveckling av nya l\u00e4kemedel f\u00f6r behandling av neurodegenerativa sjukdomar, i synnerhet Parkinsons sjukdom och demens.<\/p>\n
IRLAB har tv\u00e5 kliniska l\u00e4kemedelskandidater, IRL752 och IRL790, inriktade mot medicinska behov vid Parkinsons sjukdom, samt ytterligare projekt i preklinisk fas.<\/p>\n
IRLAB:s forskning syftar till att uppt\u00e4cka och utveckla nya l\u00e4kemedelskandidater f\u00f6r behandling av hj\u00e4rnans sjukdomar, d\u00e4r stora medicinska behov idag f\u00f6religger. Med hj\u00e4lp av den unika systembiologiska forskningsplattformen, ISP, uppt\u00e4cks dess nya behandlingsprinciper.<\/p>\n
IRLAB \u00e4r baserat i G\u00f6teborg. IRLAB:s verksamhet bedrivs huvudsakligen genom dotterbolaget Integrative Research Laboratories Sweden AB.<\/p>\n
F\u00f6r mer information, v\u00e4nligen bes\u00f6k\u00a0www.irlab.se<\/a>.<\/p>\n<\/div>\n
[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"
IRLAB har erh\u00e5llit notice of allowance fr\u00e5n United States Patent and Trademark Office (USPTO) avseende ett patent riktat mot n\u00e4sta generation substanser f\u00f6r behandling av hj\u00e4rnans sjukdomar. Detta betyder att ett patent, baserat p\u00e5 uppt\u00e4ckter gjorda med IRLAB forskningsplattform, ISP, och som avser nyckelsubstanser inom forskningsprogrammet P001, kommer att godk\u00e4nnas.<\/p>\n","protected":false},"template":"","class_list":["post-9141","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB har erh\u00e5llit notice of allowance fr\u00e5n United States Patent and Trademark Office (USPTO) avseende ett patent riktat mot n\u00e4sta generation substanser f\u00f6r behandling av hj\u00e4rnans sjukdomar. Detta betyder att ett patent, baserat p\u00e5 uppt\u00e4ckter gjorda med IRLAB forskningsplattform, ISP, och som avser nyckelsubstanser inom forskningsprogrammet P001, kommer att godk\u00e4nnas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/\",\"name\":\"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2018-09-11T06:10:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB","og_description":"IRLAB har erh\u00e5llit notice of allowance fr\u00e5n United States Patent and Trademark Office (USPTO) avseende ett patent riktat mot n\u00e4sta generation substanser f\u00f6r behandling av hj\u00e4rnans sjukdomar. Detta betyder att ett patent, baserat p\u00e5 uppt\u00e4ckter gjorda med IRLAB forskningsplattform, ISP, och som avser nyckelsubstanser inom forskningsprogrammet P001, kommer att godk\u00e4nnas.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/","name":"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2018-09-11T06:10:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-har-erhallit-notice-of-allowance-for-amerikanskt-patent\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB har erh\u00e5llit notice of allowance f\u00f6r amerikanskt patent"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}